{"id":"W4242460399","doi":"10.1200/jco.2017.74.6065","title":"Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":650,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Association for Molecular Pathology; American Society of Clinical Oncology; American Association for Cancer Research","keywords":"Medicine; Atezolizumab; Nivolumab; Pembrolizumab; Oncology; Internal medicine; Lung cancer; Guideline; Docetaxel; Pemetrexed; Chemotherapy; Clinical trial; Cancer; Intensive care medicine; Immunotherapy; Pathology; Cisplatin","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1717391177742632,"score_gpt":0.6087778275094344,"score_spread":0.4370387097351712,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}